AI-generated summary
The authors randomized 56 patients who had open carpal tunnel release to receive postoperative photobiomodulation therapy (808 nm, 50 mW) or no PBMT, with 28 in each group. The PBMT group reported better function, morning pain, and several pinch strength and two-point discrimination measures at follow-up, and no side effects were reported. The authors conclude PBMT may be a valuable adjunct, though the findings were measured at multiple time points and many comparisons were reported.
- Participants
- 56
- Who or what was studied
- Patients who underwent open carpal tunnel release, randomized into PBMT (n = 28) and non-PBMT (n = 28) groups
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract reports multiple outcome comparisons at several time points without stating adjustment for multiple testing, and it does not describe blinding or long-term follow-up beyond 6 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power
- 50 mW
- Total energy
- 9 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Randomized controlled trial, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.